Under liquidation, owners and financials
CVR: 12928203
Secondary names: ALLISAN ApS, ALLISANA ApS, ALLIMAX ApS
Previous names: ApS SPKR NR. 2359, FARMASAN ApS, DANSK FARMASAN ApS
DKK -4,000
Gross profit
Net result: DKK -4,202
Michael Rasmussen (100%)
CVR · view owners
Michael Rasmussen
CVR · view management
Under liquidation
Founded 1 April 1989
CVR · view overview
0 employees
Annual report 2025 · average
Director registered: Michael Rasmussen
CVR · 19/06/2026
View the full event history
BIOMOTION PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 1989. The company is in liquidation. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANDEL OG INVESTERING AF 1989 ApS and DANSK FARMASAN A/S. The management consists of Michael Rasmussen. The company is owned by Michael Rasmussen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -4,000 and a net result of DKK -4,202 compared with DKK -6,460 the year before. Equity in the 2025 report amounted to DKK -892.
Selskabets formål er at drive virksomhed indenfor handel produktion, service og investering samt hermed beslægtede aktiviteter
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/10/2024 – 30/09/2025 | - | -4 t. | 4 t. | -892 | 0 | |
| 202401/10/2023 – 30/09/2024 | - | -6 t. | 8 t. | 3 t. | - | |
| 202301/10/2022 – 30/09/2023 | 0 | -1 t. | 11 t. | 10 t. | - | |
| 202201/10/2021 – 30/09/2022 | 16 t. | 6 t. | 12 t. | 11 t. | - | |
| 202101/10/2020 – 30/09/2021 | - | 4 t. | 6 t. | 5 t. | - | |
| 202001/10/2019 – 30/09/2020 | - | -1 t. | 3 t. | 1 t. | - | |
| 201901/10/2018 – 30/09/2019 | - | -2 t. | 4 t. | 3 t. | - | |
| 201801/10/2017 – 30/09/2018 | - | 5 t. | 5 t. | 4 t. | - | |
| 201701/10/2016 – 30/09/2017 | - | 0 | 1 | -999 | - | |
| 201601/10/2015 – 30/09/2016 | - | 0 | 251 | -999 | - | |
| 201501/10/2014 – 30/09/2015 | - | -2 t. | 1 | -999 | - | |
| 201401/10/2013 – 30/09/2014 | - | -999 | 2 t. | 983 | - | |
| 201301/10/2012 – 30/09/2013 | - | 3 t. | 3 t. | 2 t. | - | |
| 201201/10/2011 – 30/09/2012 | - | 3 t. | 0 | -1 t. | - |
Compared to 405 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationBIOMOTION PHARMA ApS is registered in the Danish CVR register with the status Under liquidation.
The CVR number of BIOMOTION PHARMA ApS is 12928203.
BIOMOTION PHARMA ApS is owned by Michael Rasmussen.
The management of BIOMOTION PHARMA ApS consists of Michael Rasmussen.
In 2025, BIOMOTION PHARMA ApS reported a gross profit of DKK -4,000.
BIOMOTION PHARMA ApS had an average of 0 employees in the 2025 financial year according to the annual report.
BIOMOTION PHARMA ApS has published its annual report for 2025. Gross profit came to DKK -4,000, and the net result was DKK -4,202.
On August 19, 2026, BIOMOTION PHARMA ApS entered liquidation.
As of June 19, 2026, Michael Rasmussen is registered as liquidator of BIOMOTION PHARMA ApS.
As of June 19, 2026, Henrik Selchau Poulsen has stepped down as liquidator of BIOMOTION PHARMA ApS.
On June 19, 2026, BIOMOTION PHARMA ApS entered liquidation.
On June 19, 2026, BIOMOTION PHARMA ApS exited liquidation.
As of May 28, 2026, Henrik Selchau Poulsen is registered as liquidator of BIOMOTION PHARMA ApS.
On May 28, 2026, BIOMOTION PHARMA ApS entered liquidation.
As of May 6, 2026, Michael Rasmussen has stepped down as liquidator of BIOMOTION PHARMA ApS.
On May 6, 2026, BIOMOTION PHARMA ApS exited liquidation.
BIOMOTION PHARMA ApS has published its annual report for 2024. Gross profit came to DKK -5,313, and the net result was DKK -6,460.
As of December 12, 2024, Michael Rasmussen is registered as liquidator of BIOMOTION PHARMA ApS.
As of December 12, 2024, Michael Rasmussen has stepped down as director of BIOMOTION PHARMA ApS.
On December 12, 2024, BIOMOTION PHARMA ApS entered liquidation.
BIOMOTION PHARMA ApS has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK -1,430.
BIOMOTION PHARMA ApS has published its annual report for 2022. Revenue came to DKK 16,000, and the net result was DKK 6,200.
As of January 5, 2023, EY Godkendt Revisionspartnerselskab has stepped down as auditor of BIOMOTION PHARMA ApS.
BIOMOTION PHARMA ApS has published its annual report for 2021. Gross profit came to DKK -1,250, and the net result was DKK 3,750.
BIOMOTION PHARMA ApS has published its annual report for 2020. Gross profit came to DKK -1,250, and the net result was DKK -1,250.
As of September 25, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of BIOMOTION PHARMA ApS.
As of September 25, 2020, JUT NR. 2180 A/S has stepped down as auditor of BIOMOTION PHARMA ApS.
BIOMOTION PHARMA ApS has published its annual report for 2019. Gross profit came to DKK -1,501, and the net result was DKK -1,501.
BIOMOTION PHARMA ApS has published its annual report for 2018. Gross profit came to DKK 5,000, and the net result was DKK 5,000.
BIOMOTION PHARMA ApS has published its annual report for 2017. The net result was DKK 0.
BIOMOTION PHARMA ApS has published its annual report for 2016. Gross profit came to DKK 0, and the net result was DKK 0.
BIOMOTION PHARMA ApS has published its annual report for 2015. Gross profit came to DKK 3,018, and the net result was DKK -1,982.
BIOMOTION PHARMA ApS has published its annual report for 2014. Gross profit came to DKK -999, and the net result was DKK -999.
BIOMOTION PHARMA ApS has published its annual report for 2013. Gross profit came to DKK 2,982, and the net result was DKK 2,982.
BIOMOTION PHARMA ApS has published its annual report for 2012. Gross profit came to DKK 2,550, and the net result was DKK 2,550.
As of October 15, 2012, Lennie Rasmussen has stepped down as director of BIOMOTION PHARMA ApS.
As of October 15, 2012, Michael Rasmussen is registered as an owner of BIOMOTION PHARMA ApS with an ownership share of 100%.
As of March 28, 2012, JUT NR. 2180 A/S has been appointed auditor of BIOMOTION PHARMA ApS.
As of March 28, 2012, EY Danmark A/S has stepped down as auditor of BIOMOTION PHARMA ApS.
As of February 18, 2009, EY Danmark A/S has been appointed auditor of BIOMOTION PHARMA ApS.
As of February 18, 2009, REVISOR-TEAM ApS has stepped down as auditor of BIOMOTION PHARMA ApS.
On November 25, 2003, the company changed its name from HANDEL OG INVESTERING AF 1989 ApS to BIOMOTION PHARMA ApS.
As of November 28, 1996, Michael Rasmussen has left the board of directors of BIOMOTION PHARMA ApS.
As of November 28, 1996, Lennie Rasmussen has left the board of directors of BIOMOTION PHARMA ApS.
As of November 28, 1996, Annette Overgaard Hansen has left the board of directors of BIOMOTION PHARMA ApS.
As of July 17, 1996, Anne Lyngholm has left the board of directors of BIOMOTION PHARMA ApS.
On March 8, 1996, the company changed its name from DANSK FARMASAN A/S to HANDEL OG INVESTERING AF 1989 ApS.
As of February 1, 1996, Michael Rasmussen has joined the board of directors of BIOMOTION PHARMA ApS.
As of February 1, 1996, Anne Lyngholm has joined the board of directors of BIOMOTION PHARMA ApS.
As of February 1, 1996, Inga Hansen has left the board of directors of BIOMOTION PHARMA ApS.
As of February 1, 1996, Michael Rasmussen is registered as director of BIOMOTION PHARMA ApS.
As of January 18, 1996, Preben Elkjær Larsen has left the board of directors of BIOMOTION PHARMA ApS.
As of February 21, 1995, Inga Hansen has left the board of directors of BIOMOTION PHARMA ApS.
As of June 1, 1994, REVISOR-TEAM ApS has stepped down as auditor of BIOMOTION PHARMA ApS.
As of September 10, 1992, Michael Rasmussen has left the board of directors of BIOMOTION PHARMA ApS.
As of September 10, 1992, Anne Lyngholm has left the board of directors of BIOMOTION PHARMA ApS.
On May 11, 1991, the company changed its name from DANSK FARMASAN ApS to DANSK FARMASAN A/S.
As of May 10, 1991, REVISOR-TEAM ApS has stepped down as auditor of BIOMOTION PHARMA ApS.
As of May 10, 1991, Michael Rasmussen has stepped down as director of BIOMOTION PHARMA ApS.
As of May 10, 1991, Michael Rasmussen has stepped down as director of BIOMOTION PHARMA ApS.
On November 9, 1989, the company changed its name from FARMASAN ApS to DANSK FARMASAN ApS.
As of November 8, 1989, Michael Alstrøm has stepped down as director of BIOMOTION PHARMA ApS.
On July 7, 1989, the company changed its name from ApS SPKR NR. 2359 to FARMASAN ApS.
As of July 6, 1989, Erik Tronborg Andersen has stepped down as auditor of BIOMOTION PHARMA ApS.
As of July 6, 1989, Per Emil Hasselbalch Stakemann has stepped down as director of BIOMOTION PHARMA ApS.
As of April 1, 1989, REVISOR-TEAM ApS has been appointed auditor of BIOMOTION PHARMA ApS.
As of April 1, 1989, REVISOR-TEAM ApS has been appointed auditor of BIOMOTION PHARMA ApS.
As of April 1, 1989, REVISOR-TEAM ApS has been appointed auditor of BIOMOTION PHARMA ApS.
As of April 1, 1989, Erik Tronborg Andersen has been appointed auditor of BIOMOTION PHARMA ApS.
As of April 1, 1989, Michael Rasmussen has joined the board of directors of BIOMOTION PHARMA ApS.
As of April 1, 1989, Preben Elkjær Larsen has joined the board of directors of BIOMOTION PHARMA ApS.
As of April 1, 1989, Lennie Rasmussen has joined the board of directors of BIOMOTION PHARMA ApS.
As of April 1, 1989, Anne Lyngholm has joined the board of directors of BIOMOTION PHARMA ApS.
As of April 1, 1989, Annette Overgaard Hansen has joined the board of directors of BIOMOTION PHARMA ApS.
As of April 1, 1989, Inga Hansen has joined the board of directors of BIOMOTION PHARMA ApS.
As of April 1, 1989, Inga Hansen has joined the board of directors of BIOMOTION PHARMA ApS.
As of April 1, 1989, Michael Rasmussen is registered as director of BIOMOTION PHARMA ApS.
As of April 1, 1989, Michael Rasmussen is registered as director of BIOMOTION PHARMA ApS.
As of April 1, 1989, Lennie Rasmussen is registered as director of BIOMOTION PHARMA ApS.
As of April 1, 1989, Michael Alstrøm is registered as director of BIOMOTION PHARMA ApS.
As of April 1, 1989, Per Emil Hasselbalch Stakemann is registered as director of BIOMOTION PHARMA ApS.
BIOMOTION PHARMA ApS was founded on April 1, 1989.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 19064301
CVR 37726508
CVR 19835081
CVR 21327581
CVR 46124723
